Skip to main content
Premium Trial:

Request an Annual Quote

To Review or Not to Review

DrugMonkey wonders about the ethics of reviewing a manuscript that you've already reviewed for another journal. The post says it's OK to accept these articles for review, but wonders if reviewers have an obligation to tell the editor that the article has already been rejected by another journal. "As an author, I think that on the whole I would prefer that the editor be informed when a reviewer has seen the paper before. As a reviewer all I can say is that I do generally indicate this to the editor," writes DrugMonkey.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.